Artigo de Periódico
Análise dos medicamentos relaxantes musculares comercializados no Brasil na perspectiva do cuidado ao idoso
Fecha
2017-07Registro en:
DOI 10.5433/15177130-2017v18n1p108
1517-7130
Autor
Nelson Machado do Carmo Júnior
Adriano Max Moreira Reis
Institución
Resumen
OBJECTIVE: To analyze the scientific evidence regarding the therapeutic use and safety of muscle relaxant medicines registered in Brazil from the perspective of the health of the elderly. METHODS: This is a study of the analysis of the supply of medicines containing group M03B drugs – Centrally acting muscle relaxants of the Anatomical Therapeutic Chemical classification. The M03B group drugs registered in Brazil were observed. The scientific evidence on safety and efficacy has been investigated. The availability of safety information in the package leaflet was analyzed. RESULTS: We identified 18 drugs from group M03B, of which 7 (38.9%) are registered in Brazil. Of the 67 specialties registered, 35 (52.2%) are pharmacological associations. CONCLUSION: Evidence for the use of muscle relaxants in the elderly is limited. The package leaflets do not contain relevant information on adverse events.